Simpson Thacher Represents J.P. Morgan in Offering of US$254.4 Million Principal Amount of Zero Coupon Convertible Bonds by Cathay Financial Holding Co., Ltd.

The Hong Kong office of the Firm represented J.P. Morgan in the offering of US$254.4 million principal amount of Zero Coupon Convertible Bonds (the “Bonds”) by Cathay Financial Holding Co., Ltd. (“Cathay”). Cathay is the largest financial holding company in Taiwan. The common shares of Cathay are traded on the Taiwan Stock Exchange under the trading code “2882”. The Bonds are listed on the Singapore Stock Exchange.

More >>

Tags:  Simpson Thacher & Bartlett LLP | Hong Kong

Simpson Thacher Represents Teleflex Incorporated in its Acquisition of Assets of LMA International N.V.

The Firm is representing Teleflex Incorporated (NYSE: TFX) in connection with its announced acquisition of substantially all of the assets of LMA International N.V. (“LMA”) for SGD 343.5 million in cash, which at current exchange rates translates into approximately $276 million. LMA is a public company listed on the Mainboard of the Singapore Exchange that provides laryngeal masks and other products used extensively in anesthesia and emergency care. The transaction, which is subject to customary closing conditions, is expected to close later this year.

More >>

Tags:  Simpson Thacher & Bartlett LLP | New York

Former Chicago Board of Education General Counsel Joins Jackson Lewis in Chicago

Jackson Lewis LLP, one of the country’s largest and fastest-growing workplace law firms, is pleased to announce that Patrick Rocks has joined the firm’s Chicago office as Partner. Mr. Rocks brings to Jackson Lewis over 20 years of experience in the area of public sector and education law, with a particular emphasis on both systemic class litigation and labor and employment issues facing municipalities as well as large urban school districts.

More >>

Tags:  Jackson Lewis P.C.

Willkie Advises Special Committee on Buyout of Taro Pharmaceutical Industries

On August 12, it was announced that Israel-based Taro Pharmaceutical Industries Ltd. has accepted an improved buyout offer from India-based Sun Pharmaceutical Industries Ltd., Taro’s majority shareholder. The merger agreement was approved by Taro’s Board of Directors, based upon the recommendations and approvals of its Special Committee, represented by Willkie, and its Audit Committee.

More >>

Tags:  Willkie Farr & Gallagher LLP | New York